Pharmaceutical (non-cosmetic)
Thalidomide (INN) and its salts
Safety score · 0–100
Not Rated
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
About
Thalidomide — the notorious teratogen behind one of the worst drug disasters in history. Prohibited in cosmetics under EU Annex II with no permissible use.
Thalidomide (CAS 50-35-1) is an immunomodulatory pharmaceutical best known for causing phocomelia and other severe congenital defects in an estimated 10,000-20,000 children whose mothers took it as a morning-sickness remedy in the late 1950s and early 1960s. Under CLP Regulation (EC) No 1272/2008 it is classified as H360 (may damage fertility or the unborn child) and H302 (harmful if swallowed). It is listed in Annex II of EU Regulation (EC) No 1223/2009 (Cosmetics Regulation), which prohibits its presence in cosmetic products under any circumstances. Medical use today (e.g., multiple myeloma, leprosy reactions) is tightly controlled through risk-evaluation programs like REMS. There is no legitimate cosmetic formulation, concentration, or delivery system for thalidomide.
Skin benefits
- Has no legitimate role as a cosmetic ingredient
Known concerns
- Severe teratogen
- EU Annex II — prohibited
- GHS H360/H302
- Cosmetic presence indicates adulteration
References
EU CosIng database
European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.
Related pharmaceutical (non-cosmetic)s
Check your shelf
Find Thalidomide (INN) and its salts in your products.
Scan any cosmetic product with LuxSense to see if it contains Thalidomide (INN) and its salts and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.